stars 1 stars 2 stars 3

At Bluestone Pharma®, we are dedicated to improving health with a strong focus on the human oral microbiome. Our mission is to develop and manufacture innovative and clinical efficacious probiotic formulas using proprietary technology and strong clinical evidence. This ensures that our partners gain a competitive edge in the probiotic market, driving their success. Bactoblis®, our flagship probiotic, is the most clinically tested formula for recurrent respiratory infections in children and teenagers, backed by over 30 clinical studies. Since our founding in 2013, we have expanded into 25 countries, with healthcare professionals prescribing over 200 million doses of our products globally.

Bluestone Pharma Questions

The Bluestone Pharma annual revenue was $9 million in 2026.

Steven Dijkhuizen is the COO of Bluestone Pharma.

6 people are employed at Bluestone Pharma.

The NAICS codes for Bluestone Pharma are [3254, 325, 32, 32541].

The SIC codes for Bluestone Pharma are [283, 28].

Top Bluestone Pharma Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users